Alkylation of the bovine anterior pituitary D2-dopamine receptor: Inconsistency with predictions of the ternary complex model
- 31 August 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 147 (3) , 1070-1076
- https://doi.org/10.1016/s0006-291x(87)80179-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Functional State of the Dopamine Receptor in the Anterior Pituitary Is in the High Affinity Form*Endocrinology, 1985
- Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptorsMolecular and Cellular Endocrinology, 1984
- Aporphines. 50. Kinetics of solvolysis of N-(2-chloroethyl)norapomorphine, an irreversible dopamine receptor antagonistJournal of Medicinal Chemistry, 1983
- Irreversible binding of [3H] (−) N-chloroethylnorapomorphine to mammalian brain tissueLife Sciences, 1983
- Irreversible interaction of β-haloalkylamine derivatives with dopamine D1 and D2 receptorsLife Sciences, 1983
- Irreversible blockade of [3H]spiperone- but not [3H]dopamine-labeled dopamine receptors with phenoxybenzamineBiochemical Pharmacology, 1981
- Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: Interactions with dopamine receptors of mammalian forebrain in vitroEuropean Journal of Pharmacology, 1980
- On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanismsJournal of Pharmacy and Pharmacology, 1980
- Phenoxybenzamine discriminates multiple dopamine receptorsEuropean Journal of Pharmacology, 1980
- (−)N-(Chloroethyl)norapomorphine inhibits striatal dopamine function via irreversible receptor bindingNature, 1980